SPARCL1 has been investigated in Alzheimer’s disease and multiple sclerosis, where its roles in neuroinflammation, astrocytic activation, and synaptic remodeling have been highlighted in experimental studies [25,26]. The gene discussed is SPARCL1; the disease is Alzheimer disease.